// <auto-generated/>
// Contents of: hl7.fhir.r4.core version: 4.0.1
// Minimum TypeScript Version: 3.7
// FHIR ValueSet: http://terminology.hl7.org/ValueSet/v3-ActSubstanceAdminSubstitutionCode|2014-03-26
/**
 * No Description Provided
 */
export const V3ActSubstanceAdminSubstitutionCodes = {
    /**
     * BC: Description:
     *
     *
     *                         Substitution occurred or is permitted between equivalent Brands but not Generics
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Zestril  for Prinivil
     *                            Coumadin for Jantoven
     */
    BrandComposition: "BC",
    /**
     * E: Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
     */
    Equivalent: "E",
    /**
     * EC: Description:
     *
     *
     *                         Substitution occurred or is permitted with another product that is a:
     *
     *
     *                            pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
     *                            pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
     *
     *
     *                            Examples:
     *
     *
     *
     *
     *                               Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
     *
     *                               Pharmaceutical equivalent: Lisonpril for Zestril
     */
    EquivalentComposition: "EC",
    /**
     * F: Description: This substitution was performed or is permitted based on formulary guidelines.
     */
    Formulary: "F",
    /**
     * G: Description: Substitution occurred or is permitted between equivalent Generics but not Brands
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
     */
    GenericComposition: "G",
    /**
     * N: No substitution occurred or is permitted.
     */
    None: "N",
    /**
     * TB: Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Zantac for Tagamet
     */
    TherapeuticBrand: "TB",
    /**
     * TE: Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
     *
     *
     *                            Examples:
     *
     *
     *
     *                            ranitidine for Tagamet
     */
    TherapeuticAlternative: "TE",
    /**
     * TG: Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Ranitidine  for cimetidine
     */
    TherapeuticGeneric: "TG",
};
//# sourceMappingURL=data:application/json;base64,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